Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for Hypothermia-Induced Platelet Dysfunction
NCT00902057Phase 4Unknown
- Sponsor
- The University of Hong Kong
- Start
- Jun 2009
- Primary completion
- Dec 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of desmopressin in platelet dysfunction (PFD) (4 arms), sponsored by The University of Hong Kong. Primary endpoint: closure time on PFA-100 at 3 hours. Status: unknown.
02
Drugs
desmopressin
03
Conditions
platelet dysfunction (PFD)
Beyond the preview
Go deeper on NCT00902057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902057.